{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:33:07Z","timestamp":1784302387459,"version":"3.55.0"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Superantigens (Sags) are a part of some viral or bacterial proteins that stimulate T cells and\nantigen-presenting cells leading to systemic immune repose and inflammation. SAgs might have a\npossible role in various inflammatory childhood diseases (e.g., Kawasaki disease, atopic dermatitis,\nand chronic rhinosinusitis). Worldwide studies have been conducted to determine the role of staphylococcal\nSAgs (TSST-1) in various inflammatory diseases. The SAgs (TSST-1) not only induce sepsis\nand septic shock (even in negative blood culture for S. aureus), but may also have a significant role in\nvarious childhood inflammatory diseases (e.g., KD, OMS, Polyp, dermatitis, psoriasis). In proven\nSags-induced inflammatory diseases, the inhibition of the cell-destructive process by SAgs suppressants\nmight be helpful. In toxic shock or sepsis-like presentation and even in cases with negative blood\ncultures, immediate use of anti staphylococcal drugs is required. Occasionally, the clinical presentation\nof some human viruses (e.g., coronavirus and adenovirus) mimics KD. In addition, coinfection with\nadenovirus, coronavirus, and para-influenza virus type 3 has also been observed with KD. It has been\nobserved that in developed KD, bacterial sags induced an increase in acute-phase reactants and in the\nnumber of white blood cells, and neutrophil counts. Multisystem inflammatory syndrome in children\n(MISC) and KS were observed during the recent COVID-19 pandemic. This study summarized the\nrelationship between viral and bacterial SAgs and childhood inflammatory diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526522666220530141031","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T10:47:21Z","timestamp":1653994041000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Superantigens in Various Childhood Inflammatory Diseases"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1656-2388","authenticated-orcid":true,"given":"Samileh","family":"Noorbakhsh","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases Department, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvenaz","family":"Ashouri","sequence":"additional","affiliation":[{"name":"ENT and Head and\nNeck Research Center and Department, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Moradkhani","sequence":"additional","affiliation":[{"name":"Rasoul Hospital, Iran\nUniversity of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/infdis\/167.5.997","volume":"167","author":"Patrick S.M.","year":"1993","unstructured":"Patrick S.M.; Role of superantigens in human disease. J Infect Dis 1993,167(5),997-1002","journal-title":"J Infect Dis"},{"key":"ref=2","first-page":"43: pp. (3)489-502","author":"Stow NW","year":"2003","unstructured":"Stow NW; Douglas R; Tantilipikorn P; Lacroix JS;  Superantigens 2003,43: pp. (3)489-502","journal-title":"Superantigens"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2249.2003.02203.x","volume":"133","author":"Proft T.","year":"2003","unstructured":"Proft T.; Fraser J.D.; Bacterial superantigens. Clin Exp Immunol 2003,133,299-306","journal-title":"Clin Exp Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.iy.09.040191.003525","volume":"9","author":"Herman A.","year":"1991","unstructured":"Herman A.; Kappler J.W.; Marrack P.; Pullen A.M.; Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991,9(1),745-772","journal-title":"Annu Rev Immunol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.189.1.89","volume":"189","author":"Proft T.","year":"1999","unstructured":"Proft T.; Moffatt S.L.; Berkahn C.J.; Fraser J.D.; Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 1999,189(1),89-102","journal-title":"J Exp Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/B978-0-12-800188-2.00032-X","author":"Langley R.J.","year":"2015","unstructured":"Langley R.J.; Fraser J.D.; Proft T.;  In: The comprehensive sourcebook of bacterial protein toxins 2015,911-974","journal-title":"In: The comprehensive sourcebook of bacterial protein toxins"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archotol.1988.01860190067025","volume":"114","author":"DeDio R.M.","year":"1988","unstructured":"DeDio R.M.; Tom L.W.; McGowan K.L.; Wetmore R.F.; Handler S.D.; Potsic W.P.; Microbiology of the tonsils and adenoids in a pediatric popula-tion. Arch Otolaryngol Head Neck Surg 1988,114(7),763-765","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"Wertheim H.F.","year":"2005","unstructured":"Wertheim H.F.; Melles D.C.; Vos M.C.; The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005,5(12),751-762","journal-title":"Lancet Infect Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e9452","DOI":"10.1371\/journal.pone.0009452","volume":"5","author":"Zautner A.E.","year":"2010","unstructured":"Zautner A.E.; Krause M.; Stropahl G.; Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One 2010,5(3),e9452","journal-title":"PLoS One"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00430-017-0510-5","volume":"206","author":"Radcliff F.J.","year":"2017","unstructured":"Radcliff F.J.; Clow F.; Mahadevan M.; A potential role for Staphylococcal and Streptococcal superantigens in driving skewing of TCR V\u03b2 subsets in tonsillar hyperplasia. Med Microbiol Immunol (Berl) 2017,206(4),337-346","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"ref=11","first-page":"8(Supple 4): 762s-768s7","author":"Floret D.","year":"2001","unstructured":"Floret D.;  Clinical aspects of Streptococcal and Staphylococcal toxic diseases Arch Pediatr 2001,8(Supple 4): 762s-768s7","journal-title":"Clinical aspects of Streptococcal and Staphylococcal toxic diseases Arch Pediatr"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1128\/JCM.00871-06","volume":"44","author":"Durand G.","year":"2006","unstructured":"Durand G.; Bes M.; Meugnier H.; Etienne Detection of new methicillin-resistant Staphylococcus aureous clones containing containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 2006,44(8),3053","journal-title":"J Clin Microbiol"},{"key":"ref=13","first-page":"13","volume":"53","author":"Holtfreter S.","year":"2005","unstructured":"Holtfreter S.; Broker B.M.; Staphylococcal superantigens: Do they play a role in sepsis? Arch Immunol Ther Exp 2005,53(1),13-27","journal-title":"Arch Immunol Ther Exp"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/toxins11030178","volume":"11","author":"Krakauer T.","year":"2019","unstructured":"Krakauer T.; Staphylococcal superantigens: Pyrogenic toxins induce toxic shock. Toxins (Basel) 2019,11(3),178","journal-title":"Toxins (Basel)"},{"key":"ref=15","first-page":"113","volume":"72","author":"Javadinia Sh.","year":"2014","unstructured":"Javadinia Sh.; Asgarian R.; Soboti B.; Shokrollahi M.R.; Tabatabaei A.; Toxic shock syndrome toxin level in wound samples of hospitalized children with burn: A case control. TUMJ 2014,72(2),113-120","journal-title":"TUMJ"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.burns.2004.09.017","volume":"31","author":"White M.C.","year":"2005","unstructured":"White M.C.; Thornton K.; Young A.E.; Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns 2005,31(2),193-197","journal-title":"Burns"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.otc.2005.08.006","volume":"38","author":"Kristin A.S.L.","year":"2005","unstructured":"Kristin A.S.L.; Kern R.C.; Chronic rhinosinusitis and superantigens otolaryngologic clinics of North America. Otolaryngol Clin 2005,38(6),1215-1236","journal-title":"Otolaryngol Clin"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2500\/ajr.2006.20.2880","volume":"20","author":"Conley D.B.","year":"2006","unstructured":"Conley D.B.; Tripathi A.; Seiberling K.A.; Superantigens and chronic rhinosinusitis II: Analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 2006,20(4),451-455","journal-title":"Am J Rhinol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ACI.0b013e3282f4178f","volume":"8","author":"Bachert C.","year":"2008","unstructured":"Bachert C.; Zhang N.; Patou J.; van Zele T.; Gevaert P.; Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 2008,8(Issue 1),34-38","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=20","first-page":"452","volume":"70","author":"Farhadi M.","year":"2012","unstructured":"Farhadi M.; Tabatabaei A.; Shekarabi M.; Superantigens in polyp tissue of patients with chronic rhino-sinusitis.comparative study: A brief report. TUMJ 2012,70(7),452-456","journal-title":"TUMJ"},{"key":"ref=21","first-page":"793","volume":"70","author":"Noorbakhsh S.","year":"2013","unstructured":"Noorbakhsh S.; Farhadi M.; Tabatabaei A.; Staphylococcal superantigens; toxic shock syndrome toxin-1 and enterotoxins in pediatric otitis media effusion: A brief report. TUMJ 2013,70(12),793-797","journal-title":"TUMJ"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1081-1206(10)62731-7","volume":"84","author":"Taskapan M.O.","year":"2000","unstructured":"Taskapan M.O.; Kumar P.; Role of staphylococcal superantigens in atopic dermatitis: From colonization to inflammation. Ann Allergy Asthma Immunol 2000,84(1),3-10","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1945892418801083","volume":"32","author":"Muluk N.B.","year":"2018","unstructured":"Muluk N.B.; Alt\u0131n F, Donald Y. M. Leung C Cingi, Schlievert Patrick M. Role of superantigens in allergic inflammation: Their relationship to allergic rhinitis, chronic rhinosinusitis, asthma, and atopic dermatitis. Am J Rhinol Allergy 2018,32(6),502-517","journal-title":"Am J Rhinol Allergy"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/bjd.17451","volume":"180","author":"Nowrouzian F.L.","year":"2019","unstructured":"Nowrouzian F.L.; Ljung A.; Nilsson S.; Hesselmar B.; Adlerberth I.; Wold A.E.; Neonatal gut colonization by Staphylococcus aureus strains with certain adhesins and superantigens is negatively associated with subsequent development of atopic eczema. Br J Dermatol 2019,180(6),1481-1488","journal-title":"Br J Dermatol"},{"key":"ref=25","first-page":"1","volume":"15","author":"Atefi N.","year":"2012","unstructured":"Atefi N.; Tabaie M.; Tabatabaie A.; Rezaee M.R.; Rohaninasab M.; The role of Staphylococcus superantigens in chronic plaque type psoriasis Iranian. J Dermatol 2012,15(1),1-3","journal-title":"J Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e9912","DOI":"10.5812\/jjm.9912","volume":"7","author":"Atefi N.","year":"2014","unstructured":"Atefi N.; Noorbakhsh S.; Ghavidel Darestani S.; Tabatabaei A.; Rezaee M.; The rise of staphylococcal super antigens in psoriatic patients: A case-control study. Jundishapur J Microbiol 2014,7(5),e9912","journal-title":"Jundishapur J Microbiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1002\/1521-4141(200112)31:12<3755:AID-IMMU3755>3.0.CO;2-O","volume":"31","author":"Schutyser E.","year":"2001","unstructured":"Schutyser E.; Struyf S.; Wuyts A.; Selective induction of CCL18\/PARC by staphylococcal enterotoxins in mononuclear cells and en-hanced levels in septic and rheumatoid arthritis. Eur J Immunol 2001,31(12),3755-3762","journal-title":"Eur J Immunol"},{"key":"ref=28","first-page":"e11647","volume":"7","author":"Shokrollahi M.R.","year":"2014","unstructured":"Shokrollahi M.R.; Tabatabaei Aliakbari A.; Searching the staphylococcal superantigens: Enterotoxins A, B, C, and TSST1 in synovial fluid of cases with negative culture inflammatory arthritis jundishapur. J Microbiol 2014,7(7),e11647","journal-title":"J Microbiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/S0102-09352008000200004","volume":"60","author":"Chapaval L.","year":"2008","unstructured":"Chapaval L.; Moon D.H.; Gomes, Tsai SM. An alternative method for s aureus DNA isolation. Arq Bras Med Vet Zootec 2008,60(2),299-306","journal-title":"Arq Bras Med Vet Zootec"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22203\/eCM.v004a04","volume":"4","author":"Harris L.G.","year":"2002","unstructured":"Harris L.G.; Foster S.J.; Richards R.G.; An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: Review. Eur Cell Mater 2002,4,39-60","journal-title":"Eur Cell Mater"},{"key":"ref=31","first-page":"179","year":"2006","unstructured":"Ghenghesh KHS, Ma Rialigeti K, et al PCR Detection of toxic shok syndrom toxin of Staphylococcus aureus EI-Ghodban A2006,179-182","journal-title":"Ghenghesh KHS, Ma Rialigeti K, et al PCR Detection of toxic shok syndrom toxin of Staphylococcus aureus"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-3344-0_2","volume":"1396","author":"Merriman J.A.","year":"2016","unstructured":"Merriman J.A.; Schlievert P.M.; Identification, purification, and characterization of staphylococcal superantigens. Methods Mol Biol 2016,1396,19-33","journal-title":"Methods Mol Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/B:MODI.0000025654.04427.44","volume":"8","author":"Kaempfer R.","year":"2004","unstructured":"Kaempfer R.; Peptide antagonists of superantigen toxins. Mol Divers 2004,8(2),113-120","journal-title":"Mol Divers"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/74672","volume":"6","author":"Arad G.","year":"2000","unstructured":"Arad G.; Levy R.; Hillman D.; Kaempfer R.; Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activa-tion. Nat Med 2000,6(4),414-421","journal-title":"Nat Med"},{"key":"ref=35","first-page":"520","volume":"4","author":"Kaempfer R.","year":"2002","unstructured":"Kaempfer R.; Arad G.; Levy R.; Hillman D.; Defense against biologic warfare with superantigen toxins. Isr Med Assoc J 2002,4(7),520-523","journal-title":"Isr Med Assoc J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/ITT.S125429","volume":"6","author":"Krakauer T.","year":"2017","unstructured":"Krakauer T.; FDA-approved immunosuppressants targeting Staphylococcal superantigens: Mechanisms and insights. ImmunoTargets Ther 2017,6,17-29","journal-title":"ImmunoTargets Ther"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11926-014-0423-x","volume":"16","author":"Dimitriades V.R.","year":"2014","unstructured":"Dimitriades V.R.; Brown A.G.; Gedalia A.; Kawasaki disease: Pathophysiology, clinical manifestations, and management. Curr Rheumatol Rep 2014,16(6),423","journal-title":"Curr Rheumatol Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"McCrindle B.W.","year":"2017","unstructured":"McCrindle B.W.; Rowley A.H.; Newburger J.W.; Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific state-ment for health professionals from the American heart association. Circulation 2017,135(17),e927-e999","journal-title":"Circulation"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/0140-6736(93)92752-F","volume":"342","author":"Leung D.Y.","year":"1993","unstructured":"Leung D.Y.; Meissner H.C.; Fulton D.R.; Murray D.L.; Kotzin B.L.; Schlievert P.M.; Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993,342(8884),1385-1388","journal-title":"Lancet"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/1756-185X.13213","volume":"21","author":"Rowley A.H.","year":"2018","unstructured":"Rowley A.H.; Is Kawasaki disease an infectious disorder? Int J Rheum Dis 2018,21(1),20-25","journal-title":"Int J Rheum Dis"},{"key":"ref=41","first-page":"340","volume":"24","author":"Giray T.","year":"2016","unstructured":"Giray T.; Bi\u00e7er S.; K\u00fc\u00e7\u00fck \u00d6.; Four cases with Kawasaki disease and viral infection: Aetiology or association. Infez Med 2016,24(4),340-344","journal-title":"Infez Med"},{"key":"ref=42","first-page":"18","volume":"1","author":"Bittmann S.","year":"2020","unstructured":"Bittmann S.; Weissenstein A.; Luchter E.; Mosch\u00fcring-Alieva E.; Villalon G.; Multisystem inflammatory syndrome in children (MIS-C): The role of viral superantigens in COVID-19 disease. J Allergy Infect Dis 2020,1(1),18-20","journal-title":"J Allergy Infect Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"[Epub ahead of print]","DOI":"10.1016\/j.jpeds.2020.06.045","author":"Kaushik S.","year":"2020","unstructured":"Kaushik S.; Aydin S.I.; Derespina K.R.; Bansal P.B.; Kowalsky S.; Trachtman R.; Multisystem inflammatory syndrome in children (MISC) asso-ciated with SARS-CoV-2 infection: A multi-institutional study from New York City. J Pediatr 2020,[Epub ahead of print]","journal-title":"J Pediatr"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1097\/INF.0000000000002779","volume":"39","author":"Raba A.A.","year":"2020","unstructured":"Raba A.A.; Abobaker A.; COVID-19 and Kawasaki disease: An etiology or coincidental infection? Pediatr Infect Dis J 2020,39(8),e213","journal-title":"Pediatr Infect Dis J"},{"key":"ref=45","first-page":"4","volume":"1","author":"Bittmann S","year":"2020","unstructured":"Bittmann S; Weissenstein Anne, Villalon Gloria, et al. Elisabeth Luchter: Association of COVID-19 coronavirus and Kawasaki syndrome-like features in 1-5 years old children. Neurosci Chron 2020,1(1),4-5","journal-title":"Neurosci Chron"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","volume":"5","author":"Harwood R.","year":"2021","unstructured":"Harwood R.; Allin B.; Jones C.E.; A national consensus management pathway for paediatric inflammatory multisystem syndrome tempo-rally associated with COVID-19 (PIMS-TS): Results of a national Delphi process. Lancet Child Adolesc Health 2021,5,133-141","journal-title":"Lancet Child Adolesc Health"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/febs.15512","volume":"288","author":"Leung Donald Y.M.","year":"2021","unstructured":"Leung Donald Y.M.; Kawasaki syndrome: Role of superantigens revisited. FEBS J 2021,288(6),1771-1777","journal-title":"FEBS J"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e151520","DOI":"10.1172\/JCI151520","volume":"131","author":"Porritt R.A.","year":"2021","unstructured":"Porritt R.A.; Binek A.; Paschold L.; The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest 2021,131(20),e151520","journal-title":"J Clin Invest"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e146614","DOI":"10.1172\/JCI146614","volume":"131","author":"Porritt R.A.","year":"2021","unstructured":"Porritt R.A.; Paschold L.; Rivas M.N.; HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J Clin Invest 2021,131(10),e146614","journal-title":"J Clin Invest"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e149327","DOI":"10.1172\/JCI149327","volume":"131","author":"Kouo T.","year":"2021","unstructured":"Kouo T.; Chaisawangwong W.; SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children. J Clin Invest 2021,131(10),e149327","journal-title":"J Clin Invest"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e20211381","DOI":"10.1084\/jem.20211381","volume":"219","author":"Hoste L.","year":"2022","unstructured":"Hoste L.; Roels L.; Naesens L.; MIS-C Clinicians. TIM3+TRBV11-2 T cells and IFN\u03b3 signature in patrolling monocytes and CD16+ NK cells delineate MIS-C. J Exp Med 2022,219(2),e20211381","journal-title":"J Exp Med"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220530141031","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205404\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220530141031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:18:52Z","timestamp":1693160332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205404\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526522666220530141031","relation":{},"ISSN":["1871-5265"],"issn-type":[{"value":"1871-5265","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e300522205404"}}